Heparin-induced non-necrotizing skin lesions: Rarely associated with heparin-induced thrombocytopenia

Journal of Thrombosis and Haemostasis

Volumn 8, Issue 7, 2010, Pages 1486-1491

  Schindewolf, M ^a   Kroll, H ^b   Ackermann, H ^a   Garbaraviciene, J ^a   Kaufmann, R ^a   Boehncke, W H ^a   Ludwig, R J ^a,c   Lindhoff Last, E ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b Institute for Transfusion Medicine Dessau   (Germany)

^c UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Allergy; Delayed type hypersensitivity reaction; Heparin; Heparin induced skin lesions; Heparin induced thrombocytopenia

Indexed keywords

HEPARIN; HEPARIN PLATELET FACTOR 4 ANTIBODY; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; ALLERGY TEST; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPARIN INDUCED THROMBOCYTOPENIA; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SKIN DEFECT; THROMBOCYTE COUNT;

ADOLESCENT; ADULT; COHORT STUDIES; DIAGNOSIS, COMPUTER-ASSISTED; DIAGNOSIS, DIFFERENTIAL; FEMALE; HEPARIN; HUMANS; HYPERSENSITIVITY, DELAYED; MALE; MIDDLE AGED; OBSERVATION; SKIN DISEASES; THROMBOCYTOPENIA; YOUNG ADULT;

EID: 77955036645     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2010.03795.x     Document Type: Article

References (28)

1. Ludwig RJ, Schindewolf M, Utikal J, Lindhoff-Last E, Boehncke WH. Management of cutaneous type IV hypersensitivity reactions induced by heparin. Thromb Haemost 2006, 96:611-7.
2. Blauvelt A, Hwang ST, Udey MC. 11. Allergic and immunologic diseases of the skin. J Allergy Clin Immunol 2003, 111(Suppl. 2):S560-70.
3. Warkentin TE, Roberts RS, Hirsh J, Kelton JG. Heparin-induced skin lesions and other unusual sequalae of the heparin-induced thrombocytopenia syndrome. A nested chohort study. Chest 2005, 127:1857-61.
4. Warkentin TE. Clinical picture of heparin-induced thrombocytopenia. Heparin-Induced Thrombocytopenia 2004, 53-106. Warkentin TEGreinacher A. eds, 3rd edn, New York, Marcel Dekker
5. Trautmann A, Seitz CS. Heparin allergy: delayed-type non-IgE-mediated allergic hypersensitivity to subcutaneous heparin injection. Immunol Allergy Clin North Am 2009, 29:469-80.
6. Kishimoto TK, Viswanathan K, Ganguly T, Elankumaran S, Smith S, Pelzer K, Lansing JC, Sriranganathan N, Zhao G, Galcheva-Gargova Z, Al-Hakim A, Bailey GS, Fraser B, Roy S, Rogers-Cotrone T, Buhse L, Whary M, Fox J, Nasr M, Shriver Z. Contaminated heparin associated with adverse clinical events and activation of the contact system. N Engl J Med 2008, 358:2457-67.
7. Schindewolf M, Schwaner S, Wolter M, Kroll H, Recke A, Kaufmann R, Boehncke WH, Lindhoff-Last E, Ludwig RJ. Incidence and causes of heparin-induced skin lesions. CMAJ 2009, 181:477-81.
8. Harenberg J, Huhle G, Wang L, Hoffmann U, Bayerl C, Kerowgan M. Association of heparin-induced skin lesions, intracutaneous tests and heparin-induced IgG. Allergy 1999, 54:473-7.
9. Warkentin TE. Heparin-induced skin lesions. Br J Haematol 1996, 92:494-7.
10. Lo GK, Juhl D, Warkentin TE, Sigouin CS, Eichler P, Greinacher A. Evaluation of pretest clinical score (4T's) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings. J Thromb Haemost 2006, 4:757-8.
11. Warkentin TE, Kelton JG. A 14-year study of heparin-induced thrombocytopenia. Am J Med 1996, 101:502-7.
12. Warkentin TE, Greinacher A. Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004, 126(Suppl. 3):311S-37S.
13. Eichler P, Budde U, Haas S, Kroll H, Loreth RM, Meyer O, Pachmann U, Poetzsch B, Schabel A, Albrecht A, Greinacher A. First workshop for detection of heparin-induced antibodies: validation of the heparin-induced platelet-activation test (HIPA) in comparison with PF4/heparin ELISA. Thromb Haemost 1999, 81:625-9.
14. Greinacher A, Juhl D, Strobel U, Wessel A, Lubenow N, Selleng K, Eichler P, Warkentin TE. Heparin-induced thrombocytopenia: a prospective study on the incidence, platelet-activating capacity and clinical significance of antiplatelet factor 4/heparin antibodies of the IgG, IgM, and IgA classes. J Thromb Haemost 2007, 5:1666-73.
15. Ludwig RJ, Schindewolf M, Alban S, Kaufmann R, Lindhoff-Last E, Boehncke WH. Molecular weight determines the frequency of delayed type hypersensitivity reactions to heparin and synthetic oligosaccharides. Thromb Haemost 2005, 94:1265-9.
16. Wells PS, Hirsh J, Anderson DR, Lensing AW, Foster G, Kearon C, Weitz J, D'Ovidio R, Cogo A, Prandoni P. Accuracy of clinical assessment of deep-vein thrombosis. Lancet 1995, 345:1326-30.
17. Schellong SM, Schwarz T, Halbritter K, Beyer J, Siegert G, Oettler W, Schmidt B, Schroeder HE. Complete compression ultrasonography of the leg veins as a single test for the diagnosis of deep vein thrombosis. Thromb Haemost 2003, 89:228-34.
18. Schindewolf M, Ludwig RJ, Daemgen-von-Brevern G, Linnemann B, Luxembourg B, Zgouras D, Kroll H, Wolter M, Boehncke WH, Lindhoff-Last E. Lack of necrosis or microvascular thrombosis in skin lesions of a patient with heparin-induced thrombocytopenia (HIT). Haemostaseologie 2008, 2:A72.
19. Greinacher A, Farner B, Kroll H, Kohlmann T, Warkentin TE, Eichler P. Clinical features of heparin-induced thrombocytopenia including risk factors for thrombosis. A retrospective analysis of 408 patients. Thromb Haemost 2005, 94:132-5.
20. Lo GK, Sigouin CS, Warkentin TE. What is the potential for overdiagnosis of heparin-induced thrombocytopenia? Am J Hematol 2007, 82:1037-43.
21. Warkentin TE, Sheppard JA, Sigouin CS, Kohlmann T, Eichler P, Greinacher A. Gender imbalance and risk factor interactions in heparin-induced thrombocytopenia. Blood 2006, 108:2937-41.
22. Warkentin TE, Kelton JG. Delayed-onset heparin-induced thrombocytopenia and thrombosis. Ann Intern Med 2001, 135:502-6.
23. Warkentin TE, Sheppard JA, Moore JC, Cook RJ, Kelton JG. Studies of the immune response in heparin-induced thrombocytopenia. Blood 2009, 113:4963-9.
24. Handschin AE, Trentz O, Kock HJ, Wanner GA. Low molecular weight heparin-induced skin necrosis - a systematic review. Langenbecks Arch Surg 2005, 390:249-54.
25. Visentin GP, Ford SE, Scott JP, Aster RH. Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for PF4 complexed with heparin or bound to endothelial cells. J Clin Invest 1994, 93:81-8.
26. Fausett MB, Vogtlander M, Lee RM, Esplin MS, Branch DW, Rodgers GM, Silver RM. Heparin-induced thrombocytopenia is rare in pregnancy. Am J Obstet Gynecol 2001, 185:148-52.
27. Bank I, Libourel EJ, Middeldorp S, Van Der Meer J, Buller HR. High rate of skin complications due to low-molecular-weight heparins in pregnant women. J Thromb Haemost 2003, 1:859-61.
28. Boehncke WH, Weber L, Gall H. Tolerance to intravenous administration of heparin and heparinoid in a patient with delayed-type hypersensitivity to heparins and heparinoids. Contact Dermatitis 1996, 35:73-5.